Latest filing published 08 Apr 2024 for NGM Biopharmaceuticals INC.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Suzanne Sawochka Hooper: trading record in brief
This profile gathers the share dealings of Suzanne Sawochka Hooper across 2 companies, led by Jazz Pharmaceuticals plc and NGM Biopharmaceuticals Inc. Over a trading history stretching from 9 August 2012 to 5 April 2024, the count stands at 72 filings.
Market trades split into 1 purchase (€99k) and 27 sales (€9.5M). Taken together, the sales exceed the purchases by €9.4M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 24 share grants and 18 option exercises.
The latest filing, published on 8 April 2024, reports a transaction in NGM Biopharmaceuticals Inc. The last insider purchase was made public on 10 April 2019, 2,769 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Suzanne Sawochka Hooper
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,000 sharesCommon StockSEC:0000950170-24-042600:0
- 7,000 shares@ US$16.00100.0% of flowCommon StockSEC:0001209191-19-024200:0Canonical exit: 7 Jul 2019 (T+90)
- 6,666 shares@ US$46.838.4% of flowOrdinary SharesSEC:0001765581-19-000015:2
- 6,666 shares@ US$140.0025.1% of flowOrdinary SharesSEC:0001765581-19-000015:3
- 783 shares@ US$126.252.7% of flowOrdinary SharesSEC:0001765581-19-000015:0
- 663 shares@ US$127.762.3% of flowOrdinary SharesSEC:0001765581-19-000015:1
- 3,295 shares@ US$46.833.7% of flowOrdinary SharesSEC:0001232524-18-000202:0
- 3,295 shares@ US$140.2111.1% of flowOrdinary SharesSEC:0001232524-18-000202:1
- 39 shares@ US$140.210.1% of flowOrdinary SharesSEC:0001232524-18-000202:2
- 7,500 shares@ US$165.0015.5% of flowOrdinary SharesSEC:0001232524-18-000099:0
- 8,540 shares@ US$46.835.0% of flowOrdinary SharesSEC:0001232524-18-000099:1
- 1,691 shares@ US$59.131.2% of flowOrdinary SharesSEC:0001232524-18-000099:2
- 1,239 shares@ US$143.392.2% of flowOrdinary SharesSEC:0001232524-18-000065:0
- 9,400 shares0Ordinary SharesSEC:0001232524-18-000043:0
- 1,445 shares@ US$147.442.6% of flowOrdinary SharesSEC:0001232524-18-000026:0
- 864 shares@ US$143.801.5% of flowOrdinary SharesSEC:0001232524-18-000026:1
- 4,580 shares@ US$160.009.4% of flowOrdinary SharesSEC:0001544589-17-000010:0
- 420 shares@ US$160.000.9% of flowOrdinary SharesSEC:0001544589-17-000008:0
- 2,500 shares@ US$160.005.5% of flowOrdinary SharesSEC:0001544589-17-000006:0
- 2,500 shares@ US$160.005.5% of flowOrdinary SharesSEC:0001544589-17-000004:0
- 2,087 shares@ US$132.813.9% of flowOrdinary SharesSEC:0001232524-17-000077:0
- 10,000 shares0Ordinary SharesSEC:0001232524-17-000065:0
- 2,511 shares@ US$136.974.9% of flowOrdinary SharesSEC:0001232524-17-000034:0
- 4,565 shares@ US$150.019.2% of flowOrdinary SharesSEC:0001232524-16-000313:0
- 1,832 shares@ US$127.843.2% of flowOrdinary SharesSEC:0001232524-16-000236:0
25 of 70 declarations
